] . 2019. “Safety And Efficacy Of Vrc01 Broadly Neutralising Antibodies In Adults With Acutely Treated Hiv (Rv397): A Phase 2, Randomised, Double-Blind, Placebo-Controlled Trial.”. Lancet Hiv 6 (5). Lancet Hiv: e297-e306. doi:10.1016/S2352-3018(19)30053-0.
. 2019. “Safety And Immunogenicity Of An Anti-Middle East Respiratory Syndrome Coronavirus Dna Vaccine: A Phase 1, Open-Label, Single-Arm, Dose-Escalation Trial.”. Lancet Infect Dis 19 (9). Lancet Infect Dis: 1013-1022. doi:10.1016/S1473-3099(19)30266-X.
. 2018. “Preliminary Aggregate Safety And Immunogenicity Results From Three Trials Of A Purified Inactivated Zika Virus Vaccine Candidate: Phase 1, Randomised, Double-Blind, Placebo-Controlled Clinical Trials.”. Lancet 391 (10120). Lancet: 563-571. doi:10.1016/S0140-6736(17)33106-9.